Cargando…

Serum Eotaxin-1 is Increased in Extremely Low Birth Infants with Bronchopulmonary Dysplasia or Death

BACKGROUND: Early systemic inflammation in extremely low birth weight (ELBW) infants is associated with an increased risk of bronchopulmonary dysplasia (BPD). Our objective was to identify circulating biomarkers and develop prediction models for BPD/death soon after birth. METHODS: Blood samples fro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kandasamy, Jegen, Roane, Claire, Szalai, Alexander, Ambalavanan, Namasivayam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4628573/ https://www.ncbi.nlm.nih.gov/pubmed/26270578 http://dx.doi.org/10.1038/pr.2015.152

Ejemplares similares

Mesenchymal stem cell bioenergetics and apoptosis are associated with risk for bronchopulmonary dysplasia in extremely low birth weight infants
por: Hazra, Snehashis, et al.
Publicado: (2022)

Airway nitrite is increased in extremely preterm infants with bronchopulmonary dysplasia
por: Gentle, Samuel J., et al.
Publicado: (2020)

Bronchopulmonary dysplasia is associated with reduced oral nitrate reductase activity in extremely preterm infants
por: Gentle, Samuel J., et al.
Publicado: (2020)

Biomarkers associated with bronchopulmonary dysplasia/mortality in premature infants
por: Balena-Borneman, Jessica, et al.
Publicado: (2016)

Genomics, microbiomics, proteomics, and metabolomics in bronchopulmonary dysplasia
por: Lal, Charitharth Vivek, et al.
Publicado: (2018)

Duration of Noninvasive Respiratory Support and Risk for Bronchopulmonary Dysplasia or Death
por: Gentle, Samuel J, et al.
Publicado: (2022)

Azithromycin in the extremely low birth weight infant for the prevention of Bronchopulmonary Dysplasia: a pilot study
por: Ballard, Hubert O, et al.
Publicado: (2007)

Pulmonary function in extremely low birth weight infants with bronchopulmonary dysplasia before hospital discharge
por: McEvoy, Cindy T., et al.
Publicado: (2020)

B-type natriuretic peptide and mortality in extremely low birth weight infants with pulmonary hypertension: a retrospective cohort analysis
por: Cuna, Alain, et al.
Publicado: (2014)

Neonatal ibuprofen exposure and bronchopulmonary dysplasia in extremely premature infants
por: Chen, Xueyu, et al.
Publicado: (2019)

Assessment of Corticosteroid Therapy and Death or Disability According to Pretreatment Risk of Death or Bronchopulmonary Dysplasia in Extremely Preterm Infants
por: Jensen, Erik A., et al.
Publicado: (2023)

Genetic Polymorphisms of Heme-oxygenase 1 (HO-1) may Impact on Acute Kidney Injury, Bronchopulmonary Dysplasia and Mortality in Premature Infants
por: Askenazi, David J, et al.
Publicado: (2015)

Health Care Burden of Bronchopulmonary Dysplasia Among Extremely Preterm Infants
por: Mowitz, Meredith E., et al.
Publicado: (2019)

Respiratory severity score as a predictive factor for severe bronchopulmonary dysplasia or death in extremely preterm infants
por: Jung, Young Hwa, et al.
Publicado: (2019)

Correction to: Respiratory severity score as a predictive factor for severe bronchopulmonary dysplasia or death in extremely preterm infants
por: Jung, Young Hwa, et al.
Publicado: (2019)

Improved weight attainment of extremely low-gestational-age infants with bronchopulmonary dysplasia
por: Madden, J, et al.
Publicado: (2010)

High Incidence of Rickets in Extremely Low Birth Weight Infants with Severe Parenteral Nutrition-Associated Cholestasis and Bronchopulmonary Dysplasia
por: Lee, Soon Min, et al.
Publicado: (2012)

Vitamin A to prevent bronchopulmonary dysplasia in extremely low birth weight infants: a systematic review and meta-analysis
por: Araki, Shunsuke, et al.
Publicado: (2018)

Heterogeneity of Treatment Effects of Hydrocortisone by Risk of Bronchopulmonary Dysplasia or Death Among Extremely Preterm Infants in the National Institute of Child Health and Human Development Neonatal Research Network Trial: A Secondary Analysis of a Randomized Clinical Trial
por: Gentle, Samuel J., et al.
Publicado: (2023)

Predictors of Bronchopulmonary Dysplasia in Infants With Birth Weight Less Than 1500 g
por: Maytasari, Galuh Martin, et al.
Publicado: (2023)

Pulmonary hypertension in infants with bronchopulmonary dysplasia
por: Kim, Gi Beom
Publicado: (2010)

Biomarkers for Bronchopulmonary Dysplasia in the Preterm Infant
por: Rivera, Lidys, et al.
Publicado: (2016)

Bronchopulmonary dysplasia predicted at birth by artificial intelligence
por: Verder, Henrik, et al.
Publicado: (2020)

The Angiotensin Converting Enzyme Insertion/Deletion polymorphism is not associated with an increased risk of death or bronchopulmonary dysplasia in ventilated very low birth weight infants
por: Yanamandra, Krishna, et al.
Publicado: (2004)

Trends in survival among extremely-low-birth-weight infants (less than 1000 g) without significant bronchopulmonary dysplasia
por: Botet, Francesc, et al.
Publicado: (2012)

Neonatal hematological parameters and the risk of moderate-severe bronchopulmonary dysplasia in extremely premature infants
por: Chen, Xueyu, et al.
Publicado: (2019)

The Utility of Comprehensive Metabolic Panel Tests for the Prediction of Bronchopulmonary Dysplasia in Extremely Premature Infants
por: Chen, Xueyu, et al.
Publicado: (2019)

Bronchopulmonary dysplasia in extremely premature infant with congenital lobar emphysema: a case report
por: Lin, Bingchun, et al.
Publicado: (2021)

Comparison of definitions of bronchopulmonary dysplasia to reflect the long-term outcomes of extremely preterm infants
por: Jeon, Ga Won, et al.
Publicado: (2022)

Bronchopulmonary Dysplasia in Extremely Premature Infants: A Scoping Review for Identifying Risk Factors
por: Ito, Masato, et al.
Publicado: (2023)

The Impact of Time Interval Between First Extubation and Reintubation on Bronchopulmonary Dysplasia or Death in Very Low Birth Weight Infants
por: Li, Jing, et al.
Publicado: (2022)

Predictors of Bronchopulmonary Dysplasia or Death in Premature Infants with a Patent Ductus Arteriosus
por: Chock, Valerie Y., et al.
Publicado: (2013)

Increased Regulatory T Cells Precede the Development of Bronchopulmonary Dysplasia in Preterm Infants
por: Pagel, Julia, et al.
Publicado: (2020)

Myocardial Function Maturation in Very-Low-Birth-Weight Infants and Development of Bronchopulmonary Dysplasia
por: Méndez-Abad, Paula, et al.
Publicado: (2020)

Influence of early fluid overload on bronchopulmonary dysplasia in very low-birth-weight infants
por: Li, Yu-Jie, et al.
Publicado: (2022)

The value of hematocrit for predicting bronchopulmonary dysplasia in very low birth weight preterm infants
por: Wang, Xuesong, et al.
Publicado: (2023)

Pulmonary Hypertension in Preterm Infants With Bronchopulmonary Dysplasia
por: An, Hyo Soon, et al.
Publicado: (2010)

Nutrition of preterm infants in relation to bronchopulmonary dysplasia
por: Wemhöner, Andreas, et al.
Publicado: (2011)

Utilization of Inhaled Corticosteroids for Infants with Bronchopulmonary Dysplasia
por: Slaughter, Jonathan L., et al.
Publicado: (2014)

Inhaled Bronchodilator Use for Infants with Bronchopulmonary Dysplasia
por: Slaughter, Jonathan L, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_6dokfjdt4vthqnvhj8p1hf30f1